Kids & teens (for parents) · New Jersey
Studies for children and teens in New Jersey
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
28 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant
Rutgers, The State University of New Jersey
- Location
- New Brunswick, NJ
- Eligibility basics
- Ages 1 mo–4
- RecruitingHealthy volunteers
Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism
Blinklab Limited
- Location
- Princeton, NJ
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
AbbVie
- Location
- Morristown, NJ + 11 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
AbbVie
- Location
- Morristown, NJ + 9 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Lumos Pharma
- Location
- New Brunswick, NJ + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Sanofi
- Location
- Hackensack, NJ + 9 other US sites
- Eligibility basics
- Ages 1–11 · Men only
- RecruitingPhase 2/Phase 3
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
Crinetics Pharmaceuticals Inc.
- Location
- New Brunswick, NJ + 9 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
AstraZeneca
- Location
- Northfield, NJ + 18 other US sites
- Eligibility basics
- Ages 5–11
- RecruitingPhase 3
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
AstraZeneca
- Location
- Newark, NJ + 70 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Hoffmann-La Roche
- Location
- Hackensack, NJ + 8 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
AbbVie
- Location
- Morristown, NJ + 25 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Supernus Pharmaceuticals, Inc.
- Location
- Irvington, NJ + 38 other US sites
- Eligibility basics
- Ages 4–5
- RecruitingPhase 3
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Morristown, NJ + 8 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 4
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
CorMedix Therapeutics
- Location
- Hackensack, NJ + 5 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- Neptune City, NJ + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Pfizer
- Location
- Neptune City, NJ + 54 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Morristown, NJ + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- New Brunswick, NJ + 9 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
AbbVie
- Location
- Irvington, NJ + 30 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics, Inc.
- Location
- Hackensack, NJ + 16 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Takeda
- Location
- Morristown, NJ + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
Sanofi
- Location
- New Brunswick, NJ + 4 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Verona, NJ + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
ONY
- Location
- Neptune City, NJ + 9 other US sites
- Eligibility basics
- Ages 7 mo–8 mo